Advances in hydrogen sulfide and hydrogen sulfide-releasing drugs
10.16438/j.0513-4870.2015-0635
- VernacularTitle:硫化氢及其相关药物的研究进展
- Author:
Xiao-li WANG
1
;
Zhao-ya WANG
1
;
Xiao-qiang GUO
1
;
Yi-hua ZHANG
2
;
Jian YIN
1
Author Information
1. Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education of PRC, School of Biotechnology, Jiangnan University, Wuxi 214122, China
2. Institute of Pharmaceutical Sciences, China Pharmaceutical University, Nanjing 210009, China
- Publication Type:REVIEWS
- Keywords:
hydrogen sulfide;
hydrogen sulfide-releasing drug;
cardiovascular system;
nervous system
- From:
Acta Pharmaceutica Sinica
2016;51(4):507-
- CountryChina
- Language:Chinese
-
Abstract:
Hydrogen sulfide (H2S) is considered as a new member of gasotransmitter family, following nitric oxide (NO) and carbon monoxide (CO). H2S exerts important biological effects in mammals, which has drawn more and more attention in recent years. It is proved that H2S has a role in the regulation of physiological and pathophysiological processes in the cardiovascular system and the nervous system. Several cardiovascular and nervous diseases are connected to H2S. H2S-releasing agents (also known as H2S donors) have been widely used not only as useful research tools but also potential therapeutic agents. In this review, we provide an overview of the chemistry and biology of H2S, and summarize the chemistry and biological activity of some natural and synthetic H2S donors. We introduce the developments of currently available H2S-releasing drugs including H2S-non-steroidal anti-inflammatory drugs, H2S-nervous system drugs and NO-H2S-releasing drugs. We hope this review will be a value reference in the development of H2S-releasing drugs in the treatment of cardiovascular and nervous diseases.
